Expression of Dominant-Negative Mutant DP-1 Blocks Cell Cycle Progression in G 1
Open accessThe DOI matches its Crossref record.
Abstract
Unregulated expression of the transcription factor E2F promotes the G1-to-S phase transition in cultured mammalian cells. However, there has been no direct evidence for an E2F requirement in this process. To demonstrate that E2F is obligatory for cell cycle progression, we attempted to inactivate E2F by overexpressing dominant-negative forms of one of its heterodimeric partners, DP-1. We dissected the functional domains of DP-1 and separated the region that facilitate heterodimer DNA binding from the E2F dimerization domain. Various DP-1 mutants were introduced into cells via transfection, and the cell cycle profile of the transfected cells was analyzed by flow cytometry. Expression of wild-type DP-1 or DP-1 mutants that bind to both DNA and E2F drove cells into S phase. In contrast, DP-1 mutants that retained E2F binding but lost DNA binding arrested cells in the G1 phase of the cell cycle. The DP-1 mutants that were unable to bind DNA resulted in transcriptionally inactive E2F complexes, suggesting that the G1 arrest is caused by formation of defective E2F heterodimers. Furthermore, the G1 arrest instigated by these DP-1 mutants could be rescued by coexpression of wild-type E2F or DP protein. These experiments define functional domains of DP and demonstrate a requirement for active E2F complexes in cell cycle progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Self-citationThe Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153
Lundberg, A. S., & Weinberg, R. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.753 · Cited by 1,067
Histone deacetylases, transcriptional control, and cancer
Cress, W. D., & Seto, E. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200007)184:1<1::aid-jcp1>3.0.co;2-7 · Cited by 621
Regulation of cell proliferation by the E2F transcription factors
Helin, K. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80058-0 · Cited by 490
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Centrosome duplication in mammalian somatic cells requires E2F and Cdk2–Cyclin A
Meraldi, P., Lukas, J., Fry, A. M., Bartek, J., & Nigg, E. A. (1999) · Nature Cell Biology · doi:10.1038/10054 · Cited by 475
“To investigate whether centrosome duplication might require the activity of E2F family members, we overexpressed a dominant-negative mutant (DP1-DN) of DP1, a dimerization partner essential for E2F functio”
BackgroundRas Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460
De Veylder, L., Beeckman, T., Beemster, G. T. S., de Almeida Engler, J., Ormenese, S., Maes, S., Naudts, M., Van Der Schueren, E., Jacqmard, A., Engler, G., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/21.6.1360 · Cited by 412
Duensing, S., Lee, L. Y., Duensing, A., Basile, J., Piboonniyom, S.-O., Gonzalez, S., Crum, C. P., & Münger, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170093297 · Cited by 397
The retinoblastoma protein pathway and the restriction point
Bartek, J., Bartkova, J., & Lukas, J. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80081-0 · Cited by 390
Cyclin E-induced S phase without activation of the pRb/E2F pathway.
Lukas, J., Herzinger, T., Hansen, K., Moroni, M. C., Resnitzky, D., Helin, K., Reed, S. I., & Bartek, J. (1997) · Genes & Development · doi:10.1101/gad.11.11.1479 · Cited by 378
Altiok, S., Xu, M., & Spiegelman, B. M. (1997) · Genes & Development · doi:10.1101/gad.11.15.1987 · Cited by 378
Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs
Bindra, R. S., Gibson, S. L., Meng, A., Westermark, U., Jasin, M., Pierce, A. J., Bristow, R. G., Classon, M. K., & Glazer, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2119 · Cited by 334
Self-citationUp-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis
Hershko, T., & Ginsberg, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312866200 · Cited by 322
The genetics of the E2F family of transcription factors: shared functions and unique roles
DeGregori, J. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00051-3 · Cited by 295
Lukas, C., Sørensen, C. S., Kramer, E., Santoni-Rugiu, E., Lindeneg, C., Peters, J.-M., Bartek, J., & Lukas, J. (1999) · Nature · doi:10.1038/44611 · Cited by 284
Cyclin-dependent kinases as a therapeutic target for stroke
Osuga, H., Osuga, S., Wang, F., Fetni, R., Hogan, M. J., Slack, R. S., Hakim, A. M., Ikeda, J.-E., & Park, D. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170144197 · Cited by 281
Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP
Zheng, N., Fraenkel, E., Pabo, C. O., & Pavletich, N. P. (1999) · Genes & Development · doi:10.1101/gad.13.6.666 · Cited by 271
E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis
Polager, S., Kalma, Y., Berkovich, E., & Ginsberg, D. (2002) · Oncogene · doi:10.1038/sj.onc.1205102 · Cited by 269
Induction of DNA synthesis and apoptosis are separable functions of E2F-1.
Phillips, A. C., Bates, S., Ryan, K. M., Helin, K., & Vousden, K. H. (1997) · Genes & Development · doi:10.1101/gad.11.14.1853 · Cited by 259
Role of the retinoblastoma protein in the pathogenesis of human cancer.
Sellers, W. R., & Kaelin, W. G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.11.3301 · Cited by 253
Giovanni, A., Wirtz-Brugger, F., Keramaris, E., Slack, R., & Park, D. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19011 · Cited by 240
Rosenberger, C. M., Scott, M. G., Gold, M. R., Hancock, R. E. W., & Finlay, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5894 · Cited by 209
Thymidylate synthase as an oncogene
Rahman, L., Voeller, D., Rahman, M., Lipkowitz, S., Allegra, C., Barrett, J. C., Kaye, F. J., & Zajac-Kaye, M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00080-7 · Cited by 178
Yasui, K., Arii, S., Zhao, C., Imoto, I., Ueda, M., Nagai, H., Emi, M., & Inazawa, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33683 · Cited by 171
Functional antagonism between E2F family members
Frolov, M. V., Huen, D. S., Stevaux, O., Dimova, D., Balczarek-Strang, K., Elsdon, M., & Dyson, N. J. (2001) · Genes & Development · doi:10.1101/gad.903901 · Cited by 168
“In contrast, molecules that inhibit E2F-dependent transcription lead to the accumulation of cells in G1 (Dobrowolski et al. 1994; Sellers et al. 1995; Ishizaki et al. 1996; Wu et al. 1996).”
BackgroundSelf-citationDiaz-Blanco, E., Bruns, I., Neumann, F., Fischer, J. C., Graef, T., Rosskopf, M., Brors, B., Pechtel, S., Bork, S., Koch, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404549 · Cited by 148
Loss of dE2F compromises mitochondrial function
Ambrus, A. M., Islam, A. B. M. M. K., Holmes, K. B., Moon, N. S., Lopez-Bigas, N., Benevolenskaya, E. V., & Frolov, M. V. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.10.002 · Cited by 34
“To Developme inactivate E2F, a dominant-negative form of DP1D103-126, which retains a dimerization domain but lacks a DNA-binding domain (Wu et al., 1996), was used.”
Metadata
- Authors
- Wu, C.-L., Classon, M., Dyson, N., & Harlow, E.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1996-07
- Volume
- 16
- Issue
- 7
- Pages
- 3698-3706
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2170879006
- Cited by
- 139
- References
- 0
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.